Federal Register: FDA Reclassifies STEMCELL Technologies Canada Cancer Diagnostic Kit to Reduce Regulatory Burdens
October 09, 2026
October 09, 2026
WASHINGTON, Oct. 9 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit
The Food and Drug Administration (FDA) is classifying the hematopoietic cell enrichment kit into class II. The special controls that apply to the device type are identified in this ord . . .
* * *
Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit
The Food and Drug Administration (FDA) is classifying the hematopoietic cell enrichment kit into class II. The special controls that apply to the device type are identified in this ord . . .